Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Playing Catch-UP

Playing Catch-UP

posted on Feb 10, 2007 06:56PM

I've been dealing with major job changes and have not kept up to date. I see NEC caved, but I don't wish to search all the posts about the PUBPAT issue. I'm sure eveyone here has hashed out that issue every way to Sunday. Would everyone please tell me the message boards conclusion to the big corp. end around use of Pubpat. Are they just naming the 336 only? Does anyone here think they have a point at all? With this and the S and L conversion going on still (pps can't go up because of S&L alone), is this the best buying op ever sense the .08-..13 range?

Fill me in Please

Thanks

Share
New Message
Please login to post a reply